Mack Mitchell MD FACP, FAASLD
Hepatology & Liver Transplantation
VP for Medical Affairs UT Southwestern Professor Internal Medicine University Texas Southwestern Medical Center Dallas, TX
Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-0575
Fax+1 214-645-0596
Dr. Mitchell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mack Mitchell is a gastroenterologist in Dallas, TX and is affiliated with University of Texas Southwestern Medical Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 40 years. He specializes in hepatology & liver transplantation and is experienced in general gastroenterology, hepatology, alcoholic liver disease, transplant hepatology, and biliary tract disease.
Education & Training
Vanderbilt University Medical CenterFellowship, Gastroenterology, 1980 - 1982
Johns Hopkins UniversityFellowship, Gastroenterology, 1979 - 1980- Johns Hopkins UniversityResidency, Internal Medicine, 1977 - 1979
- Johns Hopkins University School of MedicineClass of 1977
Certifications & Licensure
TX State Medical License 2011 - 2027
MD State Medical License 1979 - 2013
NC State Medical License 1996 - 2012
TN State Medical License 1980 - 1982
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis Start of enrollment: 2013 Sep 01
- Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis Start of enrollment: 2013 Aug 01
- Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis Start of enrollment: 2020 Jul 10
Publications & Presentations
PubMed
- Reply: The missing link-Return to drinking as a composite endpoint component requires deeper alcohol use disorder characterization.Srinivasan Dasarathy, Wanzhu Tu, Mack Mitchell,
Hepatology. 2025-10-28 - Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.Luis Antonio Diaz, Maja Thiele, Alexandre Louvet, Brian P Lee, Veeral Ajmera
Nature Reviews. Gastroenterology & Hepatology. 2025-09-26 - Early liver transplantation in Alcohol-Associated liver disease - evolution of practice, patient selection, management & outcomes.Thomas G Cotter, Ahmad Anouti, Lisa B VanWagner, Elizabeth C Verna, David S Goldberg
Liver Transplantation. 2025-09-22
Press Mentions
Amygdala Neurosciences Announces $5.6M Financing and Dr. Mack Mitchell's Expanded Role as CMONovember 18th, 2019
Alcohol Destroyed Their Livers. Now, They're Increasingly Getting New OnesJanuary 22nd, 2019
Southwestern Health Resources ACN Saves More Than $73M in Three YearsNovember 22nd, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
